Haleon trades up after smaller than expected GSK sale

© 2025 GlobalCapital, Derivia Intelligence Limited, company number 15235970, 4 Bouverie Street, London, EC4Y 8AX. Part of the Delinian group. All rights reserved.

Accessibility | Terms of Use | Privacy Policy | Modern Slavery Statement | Event Participant Terms & Conditions

Haleon trades up after smaller than expected GSK sale

A logo sign outside of a facility occupied by GlaxoSmithKline (GSK) in Philadelphia, Pennsylvania on November 7, 2015.

In a block trade, GSK sold 2.6% of its former joint venture with Pfizer

Unlock this article.

The content you are trying to view is exclusive to our subscribers.

To unlock this article:

Request a Free Trial or Login
Gift this article